Bardellini E, Amadori F, Conti G, Majorana A. Efficacy of the photobiomodulation therapy in the treatment of the burning mouth syndrome. Med Oral Patol Oral Cir Bucal. 2019 Nov 1;24 (6):e787-91. 

 

 

doi:10.4317/medoral.23143

http://dx.doi.org/doi:10.4317/medoral.23143

 

 

1. Jimson S, Rajesh E, Krupaa RJ, Kasthuri M. Burning mouth syndrome. J Pharm Bioallied Sci. 2015;7:194-6.
https://doi.org/10.4103/0975-7406.155899
PMid:26015707 PMCid:PMC4439667

 

2. Sun A, Wu KM, Wang YP, Lin HP, Chen HM, Chiang CP. Burning mouth syndrome: a review and update. J Oral Pathol Med. 2013;42:649-5.
https://doi.org/10.1111/jop.12101
PMid:23772971

 

3. Jääskeläinen SK. Is burning mouth syndrome a neuropathic pain condition?. Pain. 2018;159:610-3.
https://doi.org/10.1097/j.pain.0000000000001090
PMid:29257770

 

4. Aggarwal A, Panat SR. Burning mouth syndrome: a diagnostic and therapeutic dilemma. J Clin Exp Dent. 2012;4:e180-5.
https://doi.org/10.4317/jced.50764
PMid:24558551 PMCid:PMC3917644

 

5. López-Jornet P, Camacho-Alonso F, Andujar-Mateos P, Sánchez-Siles M, Gómez- García F. Burning mouth syndrome: Update. Med Oral Patol Oral Cir Bucal. 2010;15:e562-8.
https://doi.org/10.4317/medoral.15.e562
PMid:20038880

 

6. Minguez-Sanz MP, Salort-Llorca C, Silvestre-Donat FJ. Etiology of burning mouth syndrome: A review and update. Med Oral Patol Oral Cir Bucal. 2011;16:e144-8.
https://doi.org/10.4317/medoral.16.e144
PMid:21217613

 

7. Lauria G, Majorana A, Borgna M, Lombardi R, Penza P, Padovani A, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain. 2005;115:332-7.
https://doi.org/10.1016/j.pain.2005.03.028
PMid:15911160

 

8. Borsani E, Majorana A, Cocchi MA, Conti G, Bonadeo S, Padovani A, et al. Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis. Histol Histopathol. 2014;29:523-3.

 

9. Just T, Steiner S, Pau HW. Oral pain perception and taste in burning mouth syndrome. J Oral Pathol Med. 2010; 39:22-7.
https://doi.org/10.1111/j.1600-0714.2009.00824.x
PMid:19804504

 

10. Gremeau-Richard C, Woda A, Navez ML, Attal N, Bouhassira D, Gagnieu MC, et al. Topical clonazepam in stomatodynia: a randomized placebo-controlled study. Pain. 2004;108:51-7.
https://doi.org/10.1016/j.pain.2003.12.002
PMid:15109507

 

11. Lopez-Jornet P, Camacho-Alonso F, Molino-Pagan D. Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome. J Oral Pathol Med. 2013;42:295-301.
https://doi.org/10.1111/jop.12002
PMid:22957483

 

12. Miziara I, Chagury A, Vargas C, Freitas L, Mahmoud A. Therapeutic options in idiopatic burning mouth syndrome: literature review. Int Arch Otohinolaryngol. 2015;19:86-9.
https://doi.org/10.1055/s-0034-1378138
PMid:25992157 PMCid:PMC4392507

 

13. Femiano F, Gombos F, Scully C. Burning mouth syndrome: open trial of psychotherapy alone, medication with alpha-lipolic acid (thioctic acid), and combination therapy. Med Oral. 2004;9:8-13.

 

14. Yang HW, Huang YF. Treatment of burning mouth syndrome with a low-level energy diode laser. Photomed Laser Surg. 2011;29:123-5.
https://doi.org/10.1089/pho.2010.2787
PMid:20969436

 

15. Amadori F, Bardellini E, Conti G, Pedrini N, Schumacher RF, et al. A. Low-level laser therapy for treatment of chemotherapy-induced oral mucositis in childhood: a randomized double-blind controlled study. Lasers Med Sci. 2016;31:1231-6.
https://doi.org/10.1007/s10103-016-1975-y
PMid:27272517

 

16. Mizutani K, Musya Y, Wakae K, Kobayashi T, Tobe M, Taira K, et al. A clinical study on serum prostaglandin E2 with low-level laser therapy. Photomed Laser Surg. 2004;22:537-9.
https://doi.org/10.1089/pho.2004.22.537
PMid:15684758

 

17. Silva GB, Sacono NT, Othon-Leite AF, Mendonça EF, Arantes AM, Bariani C, et al. Effect of low- level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study. Laser Med Sci. 2015;30:117-126.
https://doi.org/10.1007/s10103-014-1624-2
PMid:25037968

 

18. Hagiwara S, Iwasaka H, Okuda K, Noguchi T. GaIAIs (830nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Lasers Surg Med. 2007;39:797-802.
https://doi.org/10.1002/lsm.20583
PMid:18081143

 

19. Arbabi-Kalati F, Bakhshani NM, Rasti M. Evaluation of the efficacy of low-level laser in improving the symptoms of burning mouth syndrome. J Clin Exp Dent. 2015;7:e524-7.
https://doi.org/10.4317/jced.52298
PMid:26535101 PMCid:PMC4628809

 

20. Pezelj-Ribaric S, Kqiku L, Brumini G, Urek MM, Antonić R, Kuiš D, et al. Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy. Lasers Med Sci. 2013;28:297-301.
https://doi.org/10.1007/s10103-012-1149-5
PMid:22773117

 

21. Spanemberg JC, López López J, de Figueiredo MA, Cherubini K, Salum FG. Efficacy of low-level laser therapy for the treatment of burning mouth syndrome: a randomized, controlled trial. J Biomed Opt. 2015;20:098001.
https://doi.org/10.1117/1.JBO.20.9.098001
PMid:26359814

 

22. Arduino PG, Cafaro A, Garrone M et al. A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome. Lasers Med Sci. 2016;31:811-6.
https://doi.org/10.1007/s10103-016-1897-8
PMid:26873501

 

23. Corridore D, Campus G, Guerra F, Ripari F, Sale S, et al. Validation of the Italian version of the Oral Health Impact Profile-14 (IOHIP-14). Ann Stomatol (Roma). 2014;4:239- 43.
https://doi.org/10.1186/1472-6831-14-95
PMid:25091189 PMCid:PMC4128544

 

24. Jadaud E, Bensadoun RJ. Low-level laser therapy: a standard of supportive care for cancer therapy-induced oral mucositis in head and neck cancer patients?. Laser Ther. 2012;21:297-303.
https://doi.org/10.5978/islsm.12-RE-01
PMid:24511199 PMCid:PMC3882349

 

25. Carvalho PAG, Jaguar GC, Pellizzon AC, Prado JD, Lopes RN, Alves FA. Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: a double- blind randomized study in head and neck cancer patients. Oral Oncol. 2001;47:1176-81.
https://doi.org/10.1016/j.oraloncology.2011.08.021
PMid:21911312

 

26. Simcić D1, Pezelj-Ribarić S, Grzić R, Horvat J, Brumini G, Muhvić-Urek M. Detection of salivary interleukin 2 and interleukin 6 in patients with burning mouth syndrome. Mediators Inflamm. 2006;1:54632.
https://doi.org/10.1155/MI/2006/54632
PMid:16864905 PMCid:PMC1570384

 

27. Kuten-Shorrer M, Kelley JM, Sonis ST, Treister NS. Placebo effect in burning mouth syndrome: a systematic review. Oral Diseases. 2014;20:e1-e6.
https://doi.org/10.1111/odi.12192
PMid:24164777

 

28. Cavalcanti DR, da Silveira FR. Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial. J Oral Pathol Med. 2009;38:254-61.
https://doi.org/10.1111/j.1600-0714.2008.00735.x
PMid:19175713

 

29. López-D'alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal. 2011;16:e635-40.
https://doi.org/10.4317/medoral.16942
PMid:20711135

 

30. dos Santos Lde F, de Andrade SC, Nogueira GE, Leão JC, de Freitas PM. Phototherapy on the Treatment of Burning Mouth Syndrome: A Prospective Analysis of 20 Cases. Photochem Photobiol. 2015;91:1231-6.
https://doi.org/10.1111/php.12490
PMid:26138316

 

31. Barbosa NG, Gonzaga AKG, de Sena Fernandes LL, da Fonseca AG, Queiroz SIML, et al. Evaluation of laser therapy and alpha-lipoic acid for the treatment of burning mouth syndrome: a randomized clinical trial. Lasers Med Sci. 2018;33:1255-62.
https://doi.org/10.1007/s10103-018-2472-2
PMid:29502160